Global Prenatal Testing and Newborn Screening Service Market Growth (Status and Outlook) 2023-2029

Global Prenatal Testing and Newborn Screening Service Market Growth (Status and Outlook) 2023-2029

The global Prenatal Testing and Newborn Screening Service market size is projected to grow from US$ 5364.1 million in 2022 to US$ 13860 million in 2029; it is expected to grow at a CAGR of 14.5% from 2023 to 2029.

Rapidly growing global population, rising adoption rate of obstetric testing equipment in clinics, rapid development of modern healthcare, and continuous regulation across the healthcare industry are the key factors driving the growth of prenatal testing and newborn screening services market revenue.

Prenatal testing and newborn screening are effective methods for early detection of genetic metabolic diseases.

LPI (LP Information)' newest research report, the “Prenatal Testing and Newborn Screening Service Industry Forecast” looks at past sales and reviews total world Prenatal Testing and Newborn Screening Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Prenatal Testing and Newborn Screening Service sales for 2023 through 2029. With Prenatal Testing and Newborn Screening Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prenatal Testing and Newborn Screening Service industry.

This Insight Report provides a comprehensive analysis of the global Prenatal Testing and Newborn Screening Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prenatal Testing and Newborn Screening Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prenatal Testing and Newborn Screening Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prenatal Testing and Newborn Screening Service and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prenatal Testing and Newborn Screening Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Prenatal Testing and Newborn Screening Service market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Intrusive
Non-Invasive

Segmentation by application
Hospital
Diagnostic Center
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PerkinElmer
Natera
Invitae
Centogene
Illumina
Natus Medical
Sequenom
Cradle Genomics
Hoffmann-La Roche
Quest Diagnostics
Baebies
Ravgen
Eurofins Scientific
BGI Genomics
Shanghai Biotecan Pharmaceuticals Corporation
Annaroad Gene
Guangzhou Darui Biotechnology
Beijing Berry Genomics

Please note: The report will take approximately 2 business days to prepare and deliver.